Search results
Results from the WOW.Com Content Network
(Reuters) -A jury on Friday found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company ...
(Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of ...
Similac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly bowel ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott, Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that ...
An Abbott spokesperson said the issue pertains to Similac Probiotic Tri-Blend, which is used by fewer than 200 hospitals, and that it does not apply to any of the company's infant formula products ...
Robert B. Ford is an American businessman and the thirteenth chief executive officer at Abbott Laboratories, a publicly-traded medical devices and health care company based in Abbott Park, Illinois. [1] He received a bachelor's degree from Boston College and an MBA from Haas School of Business. [2]
The case is Noriega v Abbott Laboratories, U.S. District Court, Southern District of New York, No. 23-04014. (Reporting by Jonathan Stempel in New York; Editing by Will Dunham) Show comments